5月14日下午，应我院先进材料与纳米技术系的邀请，美国斯坦福大学医学院放射系副教授Xiaoyuan Chen在力学楼314会议室为大家作了一场题为“Nanoplatform-Based Molecular Imaging and Therapy”的学术报告。报告由先进材料与纳米技术系的特聘研究员 侯仰龙">侯仰龙主持，6163am银河线路和其他学院的师生十余人听取了这次报告，生命科学学院院长饶毅教授也饶有兴致地参加了报告会。

 

    Chen教授的报告从纳米技术讲起，他指出，纳米技术作为包含化学、工程学、生物学以及医学等学科的交叉性研究领域对于疾病的早期发现、精确诊断和个性化治疗有着潜在的巨大影响。纳米颗粒可以通过克服生物、生物物理和生物医学的阻碍，作为有效定位的药物输送和影像标志的平台。在此报告中，他也通过自己研究小组的具体工作实例，详细讲解了基于纳米平台的分子影像学的巨大潜力和挑战。

 

               

 

报告人简介：

He was born in China and received his Bachelor’s degree in Chemistry from Nanjing University in 1993 followed by a Master’s degree in chemistry from the same university in 1996. He moved to Idaho the same year and spent 3 years at the University of Idaho before receiving his PhD in chemistry in 1999. After two quick postdocs at Syracuse University and Washington University in St. Louis he joined the University of Southern California as an Assistant Professor of Radiology. He then moved to Stanford University in 2004 to help build up the Molecular Imaging Program at Stanford (MIPS). Major research areas of Chen group include: 1) Development of novel molecular imaging probes to visualize and quantify the fundamental molecular processes in cancer and cardiovascular diseases; 2) Application of the state-of-the-art imaging technologies to guide and monitor molecular therapeutics; 3) Application of nanotechnology in molecular diagnostics and therapy.

He has published over 160 papers and numerous book chapters. He sits on the editorial board of 11 peer-reviewed journals and is a regular reviewer for over 30 journals. He also serves as a regular study section member on multiple NIH, DOD, and Komen foundation panels. Very recently he took the offer from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institute of Health (NIH) as a tenured Senior Investigator and Chief of Molecular Imaging and Nanomedicine Program.